- Home
- FHN vs DVA Comparison
FHN vs DVA Comparison
Compare FHN & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- DVA
- Stock Information
- Founded
- FHN 1864
- DVA 1994
- Country
- FHN United States
- DVA United States
- Employees
- FHN N/A
- DVA N/A
- Industry
- FHN Major Banks
- DVA Misc Health and Biotechnology Services
- Sector
- FHN Finance
- DVA Health Care
- Exchange
- FHN Nasdaq
- DVA Nasdaq
- Market Cap
- FHN 11.0B
- DVA 9.4B
- IPO Year
- FHN N/A
- DVA 1995
- Fundamental
- Price
- FHN $22.96
- DVA $127.94
- Analyst Decision
- FHN Buy
- DVA Hold
- Analyst Count
- FHN 19
- DVA 3
- Target Price
- FHN $24.21
- DVA $154.67
- AVG Volume (30 Days)
- FHN 11.0M
- DVA 790.0K
- Earning Date
- FHN 10-15-2025
- DVA 10-28-2025
- Dividend Yield
- FHN 2.60%
- DVA N/A
- EPS Growth
- FHN 28.04
- DVA 8.72
- EPS
- FHN 1.55
- DVA 10.20
- Revenue
- FHN $3,083,000,000.00
- DVA $13,161,328,000.00
- Revenue This Year
- FHN $11.05
- DVA $5.96
- Revenue Next Year
- FHN $3.76
- DVA $3.54
- P/E Ratio
- FHN $14.91
- DVA $12.54
- Revenue Growth
- FHN 4.62
- DVA 5.09
- 52 Week Low
- FHN $15.19
- DVA $126.07
- 52 Week High
- FHN $23.47
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- FHN 55.80
- DVA 45.56
- Support Level
- FHN $22.15
- DVA $127.88
- Resistance Level
- FHN $23.47
- DVA $131.84
- Average True Range (ATR)
- FHN 0.42
- DVA 2.47
- MACD
- FHN 0.01
- DVA 0.11
- Stochastic Oscillator
- FHN 58.96
- DVA 42.70
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.